EPO and breast carcinoma: Similarly, high expression of EPO and its receptor, EPOR, has recently been described in breast cancer cells [44, 45], and in regions of hypoxia in breast tumors, suggesting that this gene may be involved in breast tumorigenesis by promoting tissue hypoxia [44].